Logo image of OPXS

OPTEX SYSTEMS HOLDINGS INC (OPXS) Stock Fundamental Analysis

NASDAQ:OPXS - US68384X2099 - Common Stock

11.74 USD
+0.73 (+6.63%)
Last: 9/3/2025, 8:00:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to OPXS. OPXS was compared to 69 industry peers in the Aerospace & Defense industry. OPXS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. OPXS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year OPXS was profitable.
In the past year OPXS had a positive cash flow from operations.
OPXS had positive earnings in each of the past 5 years.
Of the past 5 years OPXS 4 years had a positive operating cash flow.
OPXS Yearly Net Income VS EBIT VS OCF VS FCFOPXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of 17.60%, OPXS belongs to the top of the industry, outperforming 98.55% of the companies in the same industry.
The Return On Equity of OPXS (22.20%) is better than 89.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 21.02%, OPXS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
OPXS had an Average Return On Invested Capital over the past 3 years of 13.10%. This is above the industry average of 8.22%.
The 3 year average ROIC (13.10%) for OPXS is below the current ROIC(21.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROIC 21.02%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
OPXS Yearly ROA, ROE, ROICOPXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With an excellent Profit Margin value of 13.01%, OPXS belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
OPXS's Profit Margin has declined in the last couple of years.
The Operating Margin of OPXS (16.11%) is better than 85.51% of its industry peers.
OPXS's Operating Margin has improved in the last couple of years.
OPXS has a better Gross Margin (28.02%) than 62.32% of its industry peers.
OPXS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
OPXS Yearly Profit, Operating, Gross MarginsOPXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OPXS is creating value.
Compared to 1 year ago, OPXS has more shares outstanding
The number of shares outstanding for OPXS has been reduced compared to 5 years ago.
The debt/assets ratio for OPXS has been reduced compared to a year ago.
OPXS Yearly Shares OutstandingOPXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
OPXS Yearly Total Debt VS Total AssetsOPXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 10.99 indicates that OPXS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 10.99, OPXS belongs to the best of the industry, outperforming 88.41% of the companies in the same industry.
There is no outstanding debt for OPXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.99
ROIC/WACC2.16
WACC9.71%
OPXS Yearly LT Debt VS Equity VS FCFOPXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.14 indicates that OPXS has no problem at all paying its short term obligations.
OPXS's Current ratio of 5.14 is amongst the best of the industry. OPXS outperforms 94.20% of its industry peers.
OPXS has a Quick Ratio of 2.05. This indicates that OPXS is financially healthy and has no problem in meeting its short term obligations.
OPXS has a Quick ratio of 2.05. This is in the better half of the industry: OPXS outperforms 68.12% of its industry peers.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 2.05
OPXS Yearly Current Assets VS Current LiabilitesOPXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

OPXS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.09%, which is quite impressive.
Measured over the past 5 years, OPXS shows a small growth in Earnings Per Share. The EPS has been growing by 4.27% on average per year.
OPXS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.00%.
The Revenue has been growing slightly by 6.74% on average over the past years.
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPXS Yearly Revenue VS EstimatesOPXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.86, OPXS is valued correctly.
OPXS's Price/Earnings ratio is rather cheap when compared to the industry. OPXS is cheaper than 95.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.84, OPXS is valued a bit cheaper.
Industry RankSector Rank
PE 15.86
Fwd PE N/A
OPXS Price Earnings VS Forward Price EarningsOPXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

OPXS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OPXS is cheaper than 97.10% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OPXS is valued cheaply inside the industry as 98.55% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.95
EV/EBITDA 11.06
OPXS Per share dataOPXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

OPXS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.72
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OPXS!.
Industry RankSector Rank
Dividend Yield N/A

OPTEX SYSTEMS HOLDINGS INC

NASDAQ:OPXS (9/3/2025, 8:00:02 PM)

11.74

+0.73 (+6.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)12-17 2025-12-17
Inst Owners32.94%
Inst Owner Change8.17%
Ins Owners17.29%
Ins Owner Change-6.28%
Market Cap81.12M
AnalystsN/A
Price TargetN/A
Short Float %0.49%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.86
Fwd PE N/A
P/S 2.05
P/FCF 14.95
P/OCF 13.26
P/B 3.51
P/tB 3.64
EV/EBITDA 11.06
EPS(TTM)0.74
EY6.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.79
FCFY6.69%
OCF(TTM)0.89
OCFY7.54%
SpS5.71
BVpS3.35
TBVpS3.23
PEG (NY)N/A
PEG (5Y)3.72
Profitability
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROCE 25.99%
ROIC 21.02%
ROICexc 26.24%
ROICexgc 27.42%
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
FCFM 13.74%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
ROICexc(3y)13.88%
ROICexc(5y)N/A
ROICexgc(3y)14.18%
ROICexgc(5y)N/A
ROCE(3y)16.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.64%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.31%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 130.21%
Cap/Sales 1.76%
Interest Coverage 219.38
Cash Conversion 88.75%
Profit Quality 105.63%
Current Ratio 5.14
Quick Ratio 2.05
Altman-Z 10.99
F-Score7
WACC9.71%
ROIC/WACC2.16
Cap/Depr(3y)182.71%
Cap/Depr(5y)142.72%
Cap/Sales(3y)2.57%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.62%
EBIT growth 3YN/A
EBIT growth 5Y8.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y431.2%
FCF growth 3Y-37.72%
FCF growth 5Y24.08%
OCF growth 1Y589.91%
OCF growth 3Y54.71%
OCF growth 5Y61.92%